Introducing Compass Carter Osborne Life Sciences Newsletter
April 3rd 2024
Compass Carter Osborne are delighted to announce the launch of our quarterly life sciences newsletter. Led by Principal Matt Dixon and Research Associate Ray Rodriguez, both of them aim to share the latest industry news ranging from fundraising and deals, to research and clinical trial news, as well as notable executive movements.
Overview of the first edition
In this first edition, the newsletter will outline the following:
A selection of the most notable acquisitions, investments, partnerships and IPO news from Q1 of 2024
Clinical trial, research and drug approvals – A selection of the most notable clinical trials, R&D and drug approval news from Q1 of 2024
Executive Moves – A selection of people moves & insights from Q1 2024
To read the newsletter, download the full version here:
Are you seeking a trusted partner to support your executive search in healthcare?
We bring decades of executive search experience and a proven track record of success across our dedicated sectors. Our investor clients rely on us time and again to build exceptional leadership teams that drive growth and deliver results.
